Ashburnham Latest News (Massachusetts, United States)

GLP-1 Receptor Agonists for Prediabetes Market to Reach $1,850 Million by 2025, Driven by Rising Awareness and Preventive Care Trends

Global Mitochondrial Health Supplements Market to Reach $2.35 Billion by 2025, Driven by Rising Health Awareness and Anti-Aging Demand

Collagen Peptide Supplements Market to Surpass $690 Million by 2025, Driven by 15% CAGR Through 2032

DUAL GIP AND GLP-1 RECEPTOR AGONISTS Market to Reach $1,570 Million by 2025, Driven by Rising Demand in Diabetes and Obesity Treatment

PARATHYROID HORMONE (PTH) ANALOGS Market to Reach $1.85 Billion by 2025, Driven by Growing Demand in Osteoporosis Treatment

RANK Ligand Inhibitors Market to Reach $3.35 Billion by 2025, Driven by Rising Demand in Oncology and Bone Health

SCLEROSTIN INHIBITORS Market to Reach $1.98 Billion by 2032, Driven by Osteoporosis Therapies and Biologic Advancements

OMEGA-3 Based Eye Supplements Market to Reach $1.3 Billion by 2032, Driven by Rising Eye Health Awareness and Aging Population

INTRANASAL MIGRAINE THERAPEUTICS Market to Reach $500 Million by 2025, Fueled by Rising Demand for Fast-Acting Pain Relief Solutions

INHALED AMINOGLYCOSIDE FORMULATIONS Market to Surpass $350 Million by 2025, Poised for 20% CAGR Through 2032

Natural and Plant-Based Nutraceutical Excipients Market to Reach $1,850 Million by 2025, Poised for 11% CAGR Through 2032

Gallium-68 Diagnostic Radiotracers Market to Surpass $200 Million by 2025, Fueled by Growing Adoption in Oncology and Neurology Imaging

LONG-ACTING INJECTABLE ANTIPSYCHOTICS Market to Reach $480 Million by 2025, Projected to Grow at 8% CAGR Through 2032

ALPHA-EMITTER RADIOPHARMACEUTICALS Market to Reach $1,650 Million by 2025, Driven by Rising Oncology Applications and Precision Medicine Trends

Long-Acting Injectable Antipsychotics Market to Reach $48.55 Billion by 2025, Driven by Rising Demand for Adherence-Enhancing Therapies

Therapeutic HPV Cancer Vaccines Market Expected to Reach $2.65 Billion by 2025, Driven by Advanced Immunotherapies and Rising Global Demand

INTERLEUKIN-17 (IL-17) Inhibitors Market to Reach $6.25 Billion by 2025, Driven by Autoimmune Treatment Demand and Biologic Innovation

Oleamide Slip Agent Market to Reach $285 Million by 2025, Driven by Packaging and Polymer Demand